← FDA DRUG APPROVALS

FDA NDA · NDA007794

NEOTHYLLINE

Sponsor: TEVA

APPLICATION
NDA007794
TYPE
NDA
ORIGINAL APPROVAL
1951-03-07
LATEST ACTION
1951-03-07
ROUTE
ORAL
DOSAGE FORM
ELIXIR, TABLET
MARKETING STATUS
Discontinued

Products

NEOTHYLLINEDiscontinued
DYPHYLLINE 160MG/15ML · ELIXIR · ORAL
NEOTHYLLINEDiscontinued
DYPHYLLINE 200MG · TABLET · ORAL
NEOTHYLLINEDiscontinued
DYPHYLLINE 400MG · TABLET · ORAL

Approval history

1951-03-07Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →